Analgesics (Pharmacies) - Australia & Oceania

  • Australia & Oceania
  • Revenue in the Analgesics market is projected to reach US$0.54bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.21%, resulting in a market volume of US$0.73bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$12.45 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Australia & Oceania is experiencing steady growth and development.

Customer preferences:
Customers in Australia & Oceania have shown a growing preference for analgesics purchased from pharmacies. This can be attributed to the trust and convenience associated with buying medication from a trusted source like a pharmacy. Additionally, customers in this region prioritize the quality and effectiveness of the analgesics they purchase, often opting for well-known brands that have a proven track record of delivering results.

Trends in the market:
One notable trend in the Analgesics (Pharmacies) market in Australia & Oceania is the increasing demand for natural and alternative pain relief options. Customers are becoming more conscious of the ingredients in the products they consume and are seeking out analgesics that are derived from natural sources. This trend is driven by a growing interest in holistic health and wellness, as well as a desire to avoid potential side effects associated with traditional analgesics. As a result, pharmacies in this region are expanding their product offerings to include a wider range of natural and alternative pain relief options. Another trend in the market is the rise of online pharmacies. Customers in Australia & Oceania are increasingly turning to online platforms to purchase their analgesics due to the convenience and accessibility they offer. Online pharmacies provide customers with the ability to order their medication from the comfort of their own homes and have it delivered directly to their doorstep. This trend has been accelerated by the COVID-19 pandemic, which has led to an increased reliance on e-commerce across various industries.

Local special circumstances:
Australia & Oceania is a geographically vast region with a diverse population spread across different countries and islands. This poses unique challenges in terms of distribution and accessibility of analgesics. Remote areas may have limited access to pharmacies, making it more difficult for customers in these areas to obtain the analgesics they need. As a result, there is a greater reliance on online pharmacies and delivery services to bridge this gap and ensure that customers in even the most remote areas have access to the medication they require.

Underlying macroeconomic factors:
The growing Analgesics (Pharmacies) market in Australia & Oceania can be attributed to several underlying macroeconomic factors. Firstly, the region has experienced steady population growth, which has led to an increased demand for healthcare products and services, including analgesics. Additionally, rising disposable incomes have allowed customers to allocate more of their budget towards healthcare and wellness products, further driving the growth of the market. Finally, advancements in healthcare infrastructure and access to healthcare services have also contributed to the development of the Analgesics (Pharmacies) market in Australia & Oceania.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)